Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: A 15-year follow-up from the time of diagnosis

Diabetes Care

Volumn 21, Issue 11, 1998, Pages 1861-1869

  Niskanen, Leo ^a,b   Turpeinen, Anu ^a   Penttilä, Ilkka ^a   Uusitupa, Math I J ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERGLYCEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; STROKE;

AGE FACTORS; ALBUMINURIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INCIDENCE; INSULIN; LIPOPROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEX FACTORS;

EID: 0031755303     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.11.1861     Document Type: Article

References (39)

1. Wingard DL, Barren-Connor E: Family history of diabetes and cardiovascular disease risk factors and mortality among euglycemic, borderline hyperglycemic, and diabetic adults. Am J Epidemiol 125:948-958, 1987
2. Stamler J, Vaccaro O, Neaton JD, Went-worth D for the Multiple Risk Factor Inter-vention Trial Research Group: Diabetes, other risk factors and 12-years cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16:434-444, 1993
3. Moss SEM, Klein R, Klein BEK, Meuer SM: The association of glycemia and cause-specific mortality in a diabetic population. Arch intern Med 154:2473-2479, 1994
4. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E. Pyörälä K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
5. Laakso M, Lehto S, Penttilä I, Pyörälä K: Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88:1421-1430, 1993
6. Kuusisto J, Mykkänen L, Pyör̈lä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
7. Andersson DKG, Svarsudd K: Long-term glycemic control relates to mortality in type 2 diabetes. Diabetes Care 18:1534-1543, 1995
8. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M: Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 46:1354-1359, 1997
9. Nathan DM, Meigs J, Singer DE: The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is... or is it? Lancet 350 (Suppl. 1):4-9, 1997
10. Barrett-Connor E: Does hyperglycemia really cause coronary heart disease? Diabetes Care 20:1620-1622, 1997
11. Uusitupa M, Siitonen O, Aro A, Pyörälä K: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (noninsulin-dependent) diabetic subjects. Diabetologia 28:22-27, 1988
12. Niskanen LK, Uusitupa MI, Sarlund H, Siitonen O, Pyörälä K: Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects. Diabetes Care 13:41-48, 1990
13. Niskanen L, Karjalainen J, Siitonen O, Uusitupa M: Metabolic evolution of type 2 diabetes: 10-year follow-up. J Iniern Med 236:263-270, 1994
14. World Health Organization: WHO Expert Committee on Diabetes Mellitus: Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
15. Rose GA, Blackburn H: Cardiovascular Survey Methods. Geneva, World Health Org., 1968 (WHO Monograph Ser., no. 56)
16. Penttilä IM, Voutilainen E, Laitinen R Juutilainen P: Comparison of different analytical and precipitation methods for the direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest 41:353-360, 1981
17. Fruchart J-C, Kora J, Cachera C, Clavey V, Duthilleul P, Moschetto Y: Simultaneous measurement of plasma apolipoproteins AI and apoB by electroimmunoassay Clin Chem 28:59, 1982
18. Uusitupa M, Pyörälä K, Laakso M: Metabolic control and macrovascular disease. In International Textbook of Diabetes Mellitus. Alberti KGMM, DeFronzo RA, Keen H, Zimrnet P, Eds. Chichester, U.K., Wiley, 1992, p. 1471-1485
19. Laakso M. Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K: Does NIDDM increase the risk far coronary heart disease similarly in both low- and high-risk populations? Diflbetologia 38:487-493, 1995
20. Eastman RC, Keen H: The impact of cardiovascular disease on people with diabetes: the potential for prevention, Lancet 350(Suppl. 1):29-32, 1997
21. U.K. Prospective Study Group: U.K. Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44:1249-1258, 1995
22. Knatteryd GL, Klimt CR, Levin ME, Jacobson ME, Goldner MG: Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. JAMA 240:37-42, 1978
23. Abraira C, Colwell J, Nuttall f, Sawin CT, Henderson W, Comstock JP, Emanuele NY Levin SR, Pacold I, Lee HS, the Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VACSDM) Group: Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med 157:181-188, 1997
24. Ceriello A, Giugliano D, Quatraro A, Marchi E, Barbanti M, Lefébre P: Evidence for a hyperglycaemia-dependem decrease of antithrombin III-thrombin complex formation in humans. Diabetologia 33:163-167, 1990
25. Hanssen KF: Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes 46 (Suppl. 2):S101-S103, 1997
26. Witztum JL: Role of modified lipoproteins in diabetic macroangiopathy. Diabetes 46 (Suppl. 2):S112-5113, 1997
27. Klein RL, Laimin M, Lopes-Virella MF: Isolation, characterization and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type 1 diabetic patients and nondiabetic subjects. Diabetes 44:1093-1098, 1995
28. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hard man J, Kotite L, Kunitake SI Havel RJ, Kane JP: Triglyceride-rich lipoproteins isolated by selected-affinity antiapolipoprotein B immunosorption from human atheroscle rotic plaque. Arterioscler Thromb 14:1767-1774, 1994
29. Chan L: Apolipoprotein B, the major protein component of triglyceride rich and low density lipoproiein. J Biol Chem 267:25621-25624, 1992
30. Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M: Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. Stroke 27:1986-1992, 1996
31. Hoff HF, Heideman CL, Gaubatz JW Gotto AM, Erickson EE, Jackson RL: Quantification of apolipoprotein B in grossly normal aorta. Circ Res 29:563-572, 1977
32. Yl̈-Herttuala SJaakkola O, Ehnholm C, Tikkanen MJ, Solakivi T, Särkioja T, Nikkari T: Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res 29:563-572, 1988
33. Simpson HCR, Meade TW Stirling Y, Mann JI, Chakrabarti R, Woolf L: Hypertriglyceridemia and hypercoagulability. Lancet 1:786-790, 1983
34. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer E: Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: results from the Framingham Offspring Study. Arteriosclerosis 7:483-490, 1987
35. Austin MA, King M-C, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 82:495-506, 1990
36. Mykkänen L, Kuusisto J, Haffner SM, Pyörälä K, Laakso M: Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thromb 14:518-526, 1994
37. Austin MA, Mykkänen L, Kuusisto J, Edwards KL, Nelson C, Haffner SM, Pyörälä K, Laakso M; Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 92:1770-1778, 1995
38. Gall M-A, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hoigaard P, Beck-Nielsen H, Pairing HH: Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diobetologia 34:655-661, 1991
39. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttilä I, Pyörälä K: Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologa 33:237-243, 1990